Clinical Trials Browser

Phase EARLY_PHASE1 × Brain Neoplasms × Trastuzumab × Clear all

NCT02735798 2017-05-04

64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets

Phase EARLY_PHASE1 Withdrawn

Brain Neoplasms